{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:55:38Z","timestamp":1761216938286},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.mnh.0000185982.10201.a7","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T08:02:24Z","timestamp":1128412944000},"page":"532-537","source":"Crossref","is-referenced-by-count":14,"title":["Biomarkers in chronic kidney disease: utility and issues towards better understanding"],"prefix":"10.1097","volume":"14","author":[{"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease: 6-year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"key":"R2-4-20210205","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMp038136","article-title":"Novel risk markers and clinical practice","volume":"349","author":"Manolio","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-4-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R4-4-20210205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"R5-4-20210205","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R6-4-20210205","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"R7-4-20210205","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(05)71055-2","article-title":"Renoprotective therapy: is it blood pressure or albuminuria that matters?","volume":"365","author":"De Jong","year":"2005","journal-title":"Lancet"},{"key":"R8-4-20210205","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1681\/ASN.2005050524","article-title":"Albuminuria, just a marker for cardiovascular disease, or is it more?","volume":"16","author":"De Zeeuw","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R9-4-20210205","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","article-title":"C-reactive protein is associated with renal function abnormalities in a non-diabetic population","volume":"63","author":"Stuveling","year":"2003","journal-title":"Kidney Int"},{"key":"R10-4-20210205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.ATV.0000013786.80104.D4","article-title":"C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk","volume":"22","author":"Jager","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R11-4-20210205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"R12-4-20210205","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1159\/000065018","article-title":"C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure","volume":"91","author":"Panichi","year":"2002","journal-title":"Nephron"},{"key":"R13-4-20210205","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0272-6386(03)00353-6","article-title":"Associations between circulating inflammatory markers and residual renal function in CRF patients","volume":"41","author":"Pecoits-Filho","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R14-4-20210205","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1046\/j.1523-1755.2002.00677.x","article-title":"Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study","volume":"62","author":"Sarnak","year":"2002","journal-title":"Kidney Int"},{"key":"R15-4-20210205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000045634","article-title":"Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy","volume":"85","author":"Shikano","year":"2000","journal-title":"Nephron"},{"key":"R16-4-20210205","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/ajkd.2002.31392","article-title":"Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels","volume":"39","author":"Agarwal","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R17-4-20210205","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","article-title":"Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death","volume":"51","author":"Stehouwer","year":"2002","journal-title":"Diabetes"},{"key":"R18-4-20210205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","article-title":"Biomarkers of inflammation and progression of chronic kidney disease","volume":"68","author":"Tonelli","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl","key":"R19-4-20210205","first-page":"S72","article-title":"Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients","volume":"41","author":"Chauveau","year":"1997","journal-title":"Kidney Int"},{"key":"R20-4-20210205","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1523-1755.2004.00960.x","article-title":"Mild hyperhomocysteinemia promotes renal hemodynamic dysfunction without histopathologic changes in adult rats","volume":"66","author":"Ossani","year":"2004","journal-title":"Kidney Int"},{"key":"R21-4-20210205","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1523-1755.2005.00234.x","article-title":"Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins","volume":"67","author":"Menon","year":"2005","journal-title":"Kidney Int"},{"key":"R22-4-20210205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.ki.4495353","article-title":"Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study","volume":"54","author":"Hoogeveen","year":"1998","journal-title":"Kidney Int"},{"key":"R23-4-20210205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","article-title":"Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study","volume":"44","author":"Ninomiya","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R24-4-20210205","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"Stuhlinger","year":"2002","journal-title":"JAMA"},{"key":"R25-4-20210205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000078838","article-title":"Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition","volume":"27","author":"Kielstein","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"R26-4-20210205","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"R27-4-20210205","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1681\/ASN.V132490","article-title":"Asymmetric dimethylarginine, C-reactive protein, and carotid intimamedia thickness in end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R28-4-20210205","first-page":"420","article-title":"Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program","volume":"1","author":"Tracy","year":"1988","journal-title":"Mod Pathol"},{"key":"R31-4-20210205","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R32-4-20210205","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"R33-4-20210205","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.CIR.0000148986.52696.07","article-title":"CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice. Laboratory tests available to assess inflammation-performance and standardization: a background paper","volume":"110","author":"Roberts","year":"2004","journal-title":"Circulation"},{"key":"R34-4-20210205","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1523-1755.2005.00455.x","article-title":"C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease","volume":"68","author":"Menon","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"R35-4-20210205","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1681\/ASN.2004110972","article-title":"Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling","volume":"16","author":"Tripepi","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R36-4-20210205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2796.2003.01180.x","article-title":"Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure","volume":"254","author":"Zoccali","year":"2003","journal-title":"J Intern Med"},{"key":"R37-4-20210205","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1523-1755.2005.00338.x","article-title":"Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD","volume":"67","author":"Mallamaci","year":"2005","journal-title":"Kidney Int"},{"key":"R38-4-20210205","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"issue":"Suppl 3","key":"R39-4-20210205","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1177\/089686080502503S21","article-title":"Clinical epidemiology of non-traditional risk factors in peritoneal dialysis patients","volume":"25","author":"Zoccali","year":"2005","journal-title":"Perit Dial Int"},{"key":"R40-4-20210205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1523-1755.2002.00144.x","article-title":"Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients","volume":"61","author":"Mallamaci","year":"2002","journal-title":"Kidney Int"},{"key":"R41-4-20210205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000109492.65802.AD","article-title":"Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure","volume":"109","author":"Scholze","year":"2004","journal-title":"Circulation"},{"key":"R42-4-20210205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","article-title":"Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease","volume":"13","author":"Kielstein","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R43-4-20210205","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"R44-4-20210205","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"R45-4-20210205","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.V1271508","article-title":"Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients","volume":"12","author":"Zoccali","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R46-4-20210205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(97)03034-1","article-title":"Biochemical detection of left-ventricular systolic dysfunction","volume":"351","author":"McDonagh","year":"1998","journal-title":"Lancet"},{"key":"R47-4-20210205","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"R48-4-20210205","first-page":"1212","article-title":"Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature","volume":"20","author":"Gabr","year":"2004","journal-title":"Can J Cardiol"},{"key":"R49-4-20210205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/ajkd.2002.33914","article-title":"Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"40","author":"Mallamaci","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["Current Opinion in Nephrology &amp; Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.mnh.0000185982.10201.a7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T06:11:03Z","timestamp":1626588663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041552-200511000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mnh.0000185982.10201.a7","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}